Inc., a pharmaceutical company with a market capitalization of $5.67 million, has entered into a definitive agreement with AbbVie (NYSE:ABBV) Bioresearch Center Inc., effectively selling certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback